Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemiaAndrew A. Lane, Naveen Pemmaraju, Ilene Galinsky et al.|Blood Advances|2023Cited by 45
Synergistic effects of low-dose belantamab mafodotin in combination with a gamma-secretase inhibitor (nirogacestat) in patients with relapsed/refractory multiple myeloma (RRMM): DREAMM-5 study.Sagar Lonial, Monique C. Minnema, Sebastian Grosicki et al.|Journal of Clinical Oncology|2022Cited by 25